Skip to main content

Weight, Body clinical trials at University of California Health

2 in progress, 0 open to eligible people

Showing trials for
  • Long-term Antipsychotic Pediatric Safety Trial

    Sorry, in progress, not accepting new patients

    Main LAP01 study: The purpose is to evaluate the long-term pathologic weight changes associated with multi-year risperidone or aripiprazole therapy in 3 - <18-year-old children, who have varying durations of prior antipsychotic drug exposure from the start of study Month 0 (M0). This is critical because children appear to have greater vulnerability to antipsychotic-associated weight gain than adults, and obesity has significant effects on morbidity and mortality. An additional sub-study (registry sub-study) has been added via a protocol amendment. This registry sub-study is optional for participant and only participants who participating in the main part of the study are eligible if they were 6 to less than 18 years of age at the time of the M0 visit. Participants who consent to this registry sub-study will participate in yearly in-person visits and complete monthly assessments remotely over the course of three additional years from the time of their final visit of the main LAP01 study.

    at UCLA

  • The Impact of 8 Weeks of Digital Meditation Application and Healthy Eating Program on Work Stress and Health Outcomes

    Sorry, in progress, not accepting new patients

    The aim of the present study is to test the effects of a digital meditation intervention and/or a healthy eating intervention in a sample of UCSF employees with overweight and obesity (BMI>=25kg/m2) who report mild to moderate stress. We will randomize UCSF employees to 8-weeks of a digital meditation intervention (using the commercially available application, Headspace), a healthy eating intervention, a digital meditation+healthy eating intervention, or a waitlist control condition.

    at UCSF

Last updated: